AI in drug discovery
AI in drug discovery is the application of artificial intelligence, machine learning, and deep learning across the pharmaceutical pipeline to identify drug targets, design new molecules, predict protein…
AI for Science
Explore AI for Science through related topics and the articles other pages reference most.
Explore articles
Browse subtopics: Healthcare AI
Articles that also belong to these categories. Counts cover all of AI for Science.
All articles (80)AI Models (19)Google DeepMind (18)Drug Discovery (12)AI Companies (11)Mathematics (10)AI Research (8)Artificial Intelligence (7)Healthcare AI (7)Open Source AI (6)AI Tools & Products (5)Anthropic (5)AI Agents (4)Deep Learning (4)Machine Learning (4)Google (3)Meta AI (3)AI Hardware (2)ChatGPT (2)Data Science (2)Developer Tools (2)Diffusion Models (2)Generative AI (2)Large Language Models (2)OpenAI (2)People (2)Reasoning Models (2)AI Ethics (1)AI History (1)AI Incidents & Controversies (1)Algorithms (1)Computer Science (1)Computer Vision (1)Data & Datasets (1)Neural Networks (1)Speech & Audio AI (1)
Showing 1-7 of 7 articles
AlphaGenome
AlphaGenome is a unified deep learning model developed by Google DeepMind that predicts thousands of functional genomic properties from raw DNA sequences.
AlphaGenome Atlas
AlphaGenome Atlas is a precomputed catalog of molecular-effect predictions for genetic variants, released by Google DeepMind on September 8, 2026.
AlphaMissense
AlphaMissense is a machine learning model from Google DeepMind that predicts whether a missense variant, a single amino-acid substitution in a protein, is likely to cause disease.
Brain-Computer Interface
A brain-computer interface (BCI), also called a brain-machine interface, is a system that measures activity in the nervous system and translates it into commands for an external device, bypassing muscles and…
Rentosertib
Rentosertib is an investigational oral small-molecule inhibitor of TNIK (TRAF2- and NCK-interacting kinase) developed by Insilico Medicine for idiopathic pulmonary fibrosis (IPF)
Virtual Biology Initiative
The Virtual Biology Initiative is a five-year, $500 million research program announced on April 29, 2026 by Biohub, the science organization of the Chan Zuckerberg Initiative (CZI).